The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention
- PMID: 30543829
- DOI: 10.1016/j.jhep.2018.12.001
The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention
Abstract
Background & aims: Liver cancer is a common malignant neoplasm worldwide. The etiologies for liver cancer are diverse and the incidence trends of liver cancer caused by specific etiologies are rarely studied. We therefore aimed to determine the pattern of liver cancer incidence, as well as temporal trends.
Methods: We collected detailed information on liver cancer etiology between 1990-2016, derived from the Global Burden of Disease study in 2016. Estimated annual percentage changes (EAPCs) in liver cancer age standardized incidence rate (ASR), by sex, region, and etiology, were calculated to quantify the temporal trends in liver cancer ASR.
Results: Globally, incident cases of liver cancer increased 114.0% from 471,000 in 1990 to 1,007,800 in 2016. The overall ASR increased by an average 0.34% (95% CI 0.22%-0.45%) per year in this period. The ASR of liver cancer due to hepatitis B, hepatitis C, and other causes increased between 1990 and 2016. The corresponding EAPCs were 0.22 (95% CI 0.08-0.36), 0.57 (95% CI 0.48-0.66), and 0.51 (95% CI 0.41-0.62), respectively. The ASR of liver cancer due to reported alcohol use remained stable (EAPC = 0.10, 95% CI -0.06-0.25). This increasing pattern was heterogeneous across regions and countries. The most pronounced increases were generally observed in countries with a high socio-demographic index, including the Netherlands, the UK, and the USA.
Conclusions: Liver cancer remains a major public health concern globally, though control of hepatitis B and C virus infections has contributed to the decreasing incidence in some regions. We observed an unfavorable trend in countries with a high socio-demographic index, suggesting that current prevention strategies should be reoriented, and much more targeted and specific strategies should be established in some countries to forestall the increase in liver cancer.
Lay summary: Liver cancer is a common malignant neoplasm worldwide. The incidence patterns of liver cancer caused by different etiologies varied considerably across the world. In this study, we aim to determine the pattern of liver cancer incidence as well as the temporal trends, thereby facilitating the establishment of more tailored prevention strategies for liver cancer.
Keywords: Alcohol consumption; Global liver cancer; HBV; HCV; Prevention.
Copyright © 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Global, Regional, and National Trends in Incidence and Mortality of Primary Liver Cancer and Its Underlying Etiologies from 1990 to 2019: Results from the Global Burden of Disease Study 2019.J Epidemiol Glob Health. 2023 Jun;13(2):344-360. doi: 10.1007/s44197-023-00109-0. Epub 2023 May 13. J Epidemiol Glob Health. 2023. PMID: 37178451 Free PMC article.
-
The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017.Aging (Albany NY). 2021 Jan 12;13(1):279-300. doi: 10.18632/aging.104127. Epub 2021 Jan 12. Aging (Albany NY). 2021. PMID: 33436531 Free PMC article.
-
Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China.Cancer Med. 2019 Sep;8(12):5787-5799. doi: 10.1002/cam4.2477. Epub 2019 Aug 6. Cancer Med. 2019. PMID: 31385465 Free PMC article.
-
The epidemiology and prevention of hepatocellular carcinoma.Semin Oncol. 2001 Oct;28(5):441-9. doi: 10.1016/s0093-7754(01)90137-x. Semin Oncol. 2001. PMID: 11685737 Review.
-
Risk factors of hepatocellular carcinoma--current status and perspectives.Asian Pac J Cancer Prev. 2012;13(3):743-52. doi: 10.7314/apjcp.2012.13.3.743. Asian Pac J Cancer Prev. 2012. PMID: 22631642 Review.
Cited by
-
Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease Study.Chin J Cancer Res. 2021 Feb 28;33(1):11-26. doi: 10.21147/j.issn.1000-9604.2021.01.02. Chin J Cancer Res. 2021. PMID: 33707924 Free PMC article.
-
SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma.BMC Cancer. 2023 Nov 28;23(1):1159. doi: 10.1186/s12885-023-11633-4. BMC Cancer. 2023. PMID: 38017386 Free PMC article.
-
The burden of epilepsy in the People's Republic of China from 1990 to 2019: epidemiological trends and comparison with the global burden of epilepsy.Front Neurol. 2023 Dec 11;14:1303531. doi: 10.3389/fneur.2023.1303531. eCollection 2023. Front Neurol. 2023. PMID: 38146443 Free PMC article.
-
Celestial Insights: Unraveling the Role of miR-3682-3p in Hepatocellular Carcinoma.Clin Transl Gastroenterol. 2024 Apr 1;15(4):e00690. doi: 10.14309/ctg.0000000000000690. Clin Transl Gastroenterol. 2024. PMID: 38334941 Free PMC article.
-
Global Epidemiologic Trends and Projections to 2030 in Non-Rheumatic Degenerative Mitral Valve Disease from 1990 to 2019: An Analysis of the Global Burden of Disease Study 2019.Rev Cardiovasc Med. 2024 Jul 22;25(7):269. doi: 10.31083/j.rcm2507269. eCollection 2024 Jul. Rev Cardiovasc Med. 2024. PMID: 39139442 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical